| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 12/23/2008 | US7468357 Nucleosides with anti-hepatitis B virus activity |
| 12/23/2008 | US7468270 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 12/23/2008 | CA2424664C Novel non-imidazole compounds |
| 12/23/2008 | CA2419067C Injectable composition comprising benzimidazole compound and strong alkali |
| 12/23/2008 | CA2324115C A preventive or therapeutic agent for inflammatory bowel disease comprising il-6 antagonist as an active ingredient |
| 12/23/2008 | CA2245267C Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 12/23/2008 | CA2175966C Antibacterial oral gel composition for application to dental implant areas |
| 12/22/2008 | CA2593558A1 Vaccine against clostridium perfringens |
| 12/18/2008 | WO2008153884A1 Compositions useful for treating gastroesophageal reflux disease |
| 12/18/2008 | WO2008153752A2 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 12/18/2008 | WO2008153511A1 The use of disulfiram in the treatment of gastrointestinal system ulcers |
| 12/18/2008 | WO2008153180A1 Method for production of hepatic-lobule-like cell mass from adipose-tissue-derived cell |
| 12/18/2008 | WO2008153077A1 Anti-norovirus agent, and composition comprising the same |
| 12/18/2008 | WO2008153027A1 Pyrroloquinoline derivative and use thereof |
| 12/18/2008 | WO2008152994A1 Adsorbent for medical use |
| 12/18/2008 | WO2008152753A1 Novel crystal of 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1h-benzimidazole sodium salt and process for producing the same |
| 12/18/2008 | WO2008152252A2 Rumc peptides with antimicrobial activity |
| 12/18/2008 | WO2008152207A1 Nutritional compositions |
| 12/18/2008 | WO2008151927A2 6-n-substituted benz imidazole derivatives as acid pump antagonists |
| 12/18/2008 | WO2008151677A1 Polymorphic form of granisetron base, methods for obtaining it and formulation containing it |
| 12/18/2008 | WO2008151519A1 USE OF NARINGENIN AND NARINGIN AS INHIBITORS FOR TRANSFORMING GROWTH FACTOR-β1 SIGNALING PATHWAY |
| 12/18/2008 | WO2008151515A1 Fibrate carboxylate compounds, preparation methods and uses thereof |
| 12/18/2008 | WO2008110771A3 Composition comprising an il-8 blocking agent and/or a trail blocking agent for use in the treatment of liver disease and hepatic flares |
| 12/18/2008 | WO2008104942A3 Muscarinic receptor antagonists |
| 12/18/2008 | US20080312449 New Compounds |
| 12/18/2008 | US20080312335 Liver protection compounds of the cyclohexenone type from antrodia camphorata |
| 12/18/2008 | US20080312305 Imidazoles as Gaba- B Receptor Modulators |
| 12/18/2008 | US20080312301 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof |
| 12/18/2008 | US20080312293 2-Arylpropionic Acid Derivatives and Pharmaceutical Compositions Containing Them |
| 12/18/2008 | US20080312291 Heterocyclic Gaba-b Modulators |
| 12/18/2008 | US20080312270 Compounds and methods useful for treating asthma and allergic inflammation |
| 12/18/2008 | US20080312269 Therapeutic Agents |
| 12/18/2008 | US20080312246 Substituted Piperazines as Metabotropic Glutamate Receptor Antagonists |
| 12/18/2008 | US20080312240 Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists |
| 12/18/2008 | US20080312224 Oxaphenanthrene Derivatives |
| 12/18/2008 | US20080312215 Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disorders |
| 12/18/2008 | US20080312209 Piperazine Heteroaryl Derivatives as Gpr38 Agonists |
| 12/18/2008 | US20080312199 Treatments of therapy resistant diseases and drug combinations for treating the same |
| 12/18/2008 | US20080312157 Gip analog and hybrid polypeptides with selectable properties |
| 12/18/2008 | US20080311232 Cooling Compounds |
| 12/18/2008 | US20080311204 Stable oral formulation containing benzimidazole derivative |
| 12/18/2008 | US20080311179 for treating disease or condition chosen from Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, sleep, eating disorders |
| 12/18/2008 | US20080311167 Topical Composition for Treating Pain |
| 12/18/2008 | US20080311115 Atherosclerosis, rheumatoid arthritis (RA), psoriasis, psoriatic arthritis, bacteria-induced gastric ulcer, and acute renal failure |
| 12/18/2008 | US20080311113 Method for treating adamts-5-associated disease |
| 12/18/2008 | US20080311097 Treatment of Ibd and Ibs Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors |
| 12/18/2008 | US20080311094 Isolated Liver Stem Cells |
| 12/18/2008 | US20080311080 Bifidobacterium in the treatment of inflammatory disease |
| 12/18/2008 | US20080311056 treating and preventing tooth decay; remove selectively cariogenic bacteria or to decrease the number of cariogenic bacteria inside oral cavity, and may exert preventive effect against tooth caries |
| 12/18/2008 | DE102007049063A1 Leberschutzverbindungen des Cyclohexenontyps aus Antrodia camphorata Hepatoprotective compounds of Antrodia camphorata from Cyclohexenontyps |
| 12/18/2008 | CA2727531A1 Uniformly abrasive confectionery product and process therefor |
| 12/18/2008 | CA2692251A1 Nutritional compositions |
| 12/18/2008 | CA2690581A1 Compositions useful for treating gastroesophageal reflux disease |
| 12/18/2008 | CA2687172A1 Anti-norovirus agent and composition containing the same |
| 12/17/2008 | EP2003140A2 Galactose derivative, drug carrier and medicinal composition |
| 12/17/2008 | EP2003130A2 Novel pyridine derivative having anti-helicobacter pylori activity |
| 12/17/2008 | EP2002842A2 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator |
| 12/17/2008 | EP2002831A1 R-Bambuterol, its preparation and therapeutic uses |
| 12/17/2008 | EP2002830A1 Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite |
| 12/17/2008 | EP2002730A1 Pinolenic acid compositions for treating fatty liver |
| 12/17/2008 | EP2001856A1 Crystalline forms of n- {2-tert -butyl -1- [ (4,4- dif luorocyclohexyl) methyl]-lh-benzimidazol-5- yl}ethanesulfonamide salts |
| 12/17/2008 | EP2001483A1 Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine |
| 12/17/2008 | EP2001313A2 Antimicrobial preparations |
| 12/17/2008 | EP1843791A4 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 12/17/2008 | EP1809607B1 Sulfonyl benzimidazole derivatives |
| 12/17/2008 | EP1532131B1 Motilide compounds |
| 12/17/2008 | EP1509234B1 Treatment of mucositis |
| 12/17/2008 | EP1443046B1 Novel 4-(2furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 12/17/2008 | EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 12/17/2008 | EP1423106B1 Arylsulfonyl derivatives with 5-ht 6 receptor affinity |
| 12/17/2008 | EP1333865B1 Inorganic low density radionuclide coated particles |
| 12/17/2008 | EP1274449B1 Methods for manipulating upper gastrointestinal transit, blood flow, for inducing satiety |
| 12/17/2008 | EP1255742B1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors |
| 12/17/2008 | EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 12/17/2008 | EP1077943B1 Heterocyclic inhibitors of p38 |
| 12/17/2008 | EP0966297B1 Regulation of gastrointestinal motility |
| 12/17/2008 | CN101326192A Novel dihydropseudoerythromycin derivatives |
| 12/17/2008 | CN101326168A Prokineticin 1 receptor antagonists |
| 12/17/2008 | CN101325962A Enhancer of cholinesterase activity |
| 12/17/2008 | CN101323850A Lactobacillus helveticus microcapsule, preparation and use thereof |
| 12/17/2008 | CN101323828A Formula of hawthorn wine |
| 12/17/2008 | CN101323648A Extraction method and and purification method of Sanghuang mushroom polysaccharide |
| 12/17/2008 | CN101323634A Induced nuclear receptor TR3 expressed cardiac glycoside compounds and use thereof |
| 12/17/2008 | CN101322847A Anti-hepatitis b virus gene medicament based on siRNA pool interference and mediated by complex carrier |
| 12/17/2008 | CN101322834A External-use Chinese patent medicine for treating children's lax |
| 12/17/2008 | CN101322827A Chinese medicinal composition for treating chronic atrophic gastritis and preparation thereof |
| 12/17/2008 | CN101322826A Chinese medicine for treating cholecystitis and method of preparing the same |
| 12/17/2008 | CN101322822A Animal and plant material soaked in wine for tonifying kidney and strengthening body |
| 12/17/2008 | CN101322821A Health preserving wine and preparation |
| 12/17/2008 | CN101322809A Ultra-high biomass high activity Chinese medicine preparation series for regenerating biological reaction, activating blood circulation and resolving stasis |
| 12/17/2008 | CN101322790A Wine for freeing channels and preparation thereof |
| 12/17/2008 | CN101322784A Medicament with stomach-regulating and antidiarrheal efficacy and producing method thereof |
| 12/17/2008 | CN101322777A Health wine |
| 12/17/2008 | CN101322770A Compound creat formulation for resisting infection |
| 12/17/2008 | CN101322751A Powder for treating tooth pain |
| 12/17/2008 | CN101322745A Medicament for treating inflammation |
| 12/17/2008 | CN101322742A Health care face-nursing formulation |
| 12/17/2008 | CN101322741A Chinese medicinal composition for treating periodontitis and preparation thereof |
| 12/17/2008 | CN101322735A Optimizing method for attenuation processing of Tripterygium wilfordii and related formulation |
| 12/17/2008 | CN101322726A Chinese medicine preparation containing Hippochaete ramosissimum total flavones and use for preparing medicament for treating hepatitis |